From: Design, synthesis, and biological activity of novel 1,2,4-oxadiazole derivatives
Compounds | M. incognita | R. solani |
---|---|---|
Corrected mortality rate (%)a、 | Inhibition rate (%)b | |
5a | 33.4 ± 2.7 | 28.7 ± 1.3 |
5b | 28.9 ± 5.2 | 15.6 ± 0.7 |
5c | 37.6 ± 8.1 | 25.2 ± 2.2 |
5d | 26.6 ± 2.0 | 20.4 ± 1.2 |
5e | 0 | 18.8 ± 1.7 |
5f | 29.5 ± 2.7 | 34.6 ± 2.3 |
5 g | 31.3 ± 5.3 | 16.1 ± 1.1 |
5 h | 29.4 ± 6.1 | 19.1 ± 0.5 |
5i | 40.3 ± 1.8 | 23.5 ± 1.6 |
5j | 39.7 ± 4.2 | 15.0 ± 2.3 |
5 k | 14.7 ± 27 | 34.7 ± 0.8 |
5 l | 31.3 ± 3.8 | 22.1 ± 0.8 |
5 m | 48.0 ± 3.7 | 23.8 ± 3.2 |
5n | 63.3 ± 7.7 | 29.4 ± 1.0 |
5o | 35.5 ± 2.4 | 47.0 ± 1.7 |
5p | 25.3 ± 3.7 | 10.4 ± 0.6 |
5q | 44.8 ± 6.7 | 26.1 ± 0.8 |
5r | 36.7 ± 5.0 | 29.1 ± 0.5 |
5 s | 27.3 ± 8.8 | 13.3 ± 1.6 |
5t | 35.6 ± 3.4 | 25.8 ± 1.3 |
5u | 40.8 ± 3.4 | 34.5 ± 2.3 |
5v | 55.0 ± 7.7 | 34.3 ± 0.3 |
5w | 26.6 ± 4.0 | 32.9 ± 1.1 |
5x | 47.3 ± 3.8 | 13.6 ± 3.2 |
5y | 34.6 ± 2.4 | 39.4 ± 1.4 |
5z | 36.5 ± 2.6 | 27.8 ± 1.6 |
Tioxazafen | 29.0 ± 4.5 | NT |
Fluopicolide | 100 | NT |
Azoxystrobin | NT | 100 |